{"id":6635,"date":"2025-05-13T12:16:41","date_gmt":"2025-05-13T06:46:41","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=6635"},"modified":"2025-05-13T12:59:17","modified_gmt":"2025-05-13T07:29:17","slug":"care-ratings-q4-results","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/quarterly-results\/care-ratings-q4-results\/","title":{"rendered":"CARE Ratings Ltd. Q4 Results Highlights: Net Profit Rises 76.4% YoY, Final Dividend of \u20b911 per share"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]CARE Ratings Ltd<\/a> released its financial results for the fourth quarter of FY25 on Tuesday, May 12, 2025.<\/span><\/p>\n

In CARE Ratings Q4 results, the company posted a <\/span>consolidated <\/span>net profit of <\/span>\u20b943.4 crore<\/span>. This marks a robust rise year-on-year (YoY) of 76.4% from <\/span>\u20b924.6<\/span> crore reported in the same quarter of the previous fiscal year.<\/span><\/p>\n

Following this result, the shares opened 5.77% higher at \u20b91,422 (the previous close was \u20b91,344.4).<\/span><\/p>\n

For the final quarter of FY25, CARE Ratings Ltd.’s revenue from operations reached <\/span>\u20b9109.7 crore<\/span>. It is around 21.8% <\/span>up <\/span>from \u20b990.1 crore in the corresponding quarter last year.<\/span><\/p>\n

Furthermore, <\/span>CARE Ratings Q4 results revealed that the total revenue increased to \u20b9124.8 crore in Q4 FY25, an improvement from \u20b9100.4 crore reported in the same period the previous year.<\/span><\/p>\n

<\/span>CARE Ratings Ltd. Q4 Results Highlights<\/b><\/span><\/h2>\n

In this table, you will get an overview of <\/span>CARE Ratings latest quarterly results:<\/p>\n\n\n\n\n\n\n
<\/td>\nQ4 FY 2024-25<\/b><\/td>\nQ3 FY 2024-25<\/b><\/td>\nQ4 FY 2023-24<\/b><\/td>\nYoY Growth (%)<\/b><\/td>\nQoQ Growth (%)<\/b><\/td>\n<\/tr>\n
Total Income (\u20b9 in crore)<\/b><\/td>\n\u20b9124.8<\/span><\/td>\n\u20b9108.2<\/span><\/td>\n\u20b9100.4<\/span><\/td>\n24.3%<\/span><\/td>\n15.3%<\/span><\/td>\n<\/tr>\n
Net profit (\u20b9 in crore)<\/b><\/td>\n\u20b943.4<\/span><\/td>\n\u20b928.4<\/span><\/td>\n\u20b924.6<\/span><\/td>\n76.4%<\/span><\/td>\n52.8%<\/span><\/td>\n<\/tr>\n
EPS (Diluted)<\/b><\/td>\n\u20b914.2\u00a0<\/span><\/td>\n\u20b99.2<\/span><\/td>\n\u20b98<\/span><\/td>\n77.5%<\/span><\/td>\n54.3%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>CARE Ratings Ltd\u2019s Financial Results Comparison with the Previous Year<\/b><\/span><\/h2>\n

Here is a table of annual data comparison of <\/span>CARE Ratings Q4 2025 results:<\/p>\n\n\n\n\n\n\n
<\/td>\nFY 2024-25<\/b><\/td>\nFY 2023-24<\/b><\/td>\n<\/tr>\n
Total Income (in crore)<\/b><\/td>\n\u20b9453<\/span><\/td>\n\u20b9378.4<\/span><\/td>\n<\/tr>\n
Net profit (in crore)<\/b><\/td>\n\u20b9140\u00a0<\/span><\/td>\n\u20b9102.6<\/span><\/td>\n<\/tr>\n
EPS<\/b><\/td>\n\u20b945.7\u00a0<\/span><\/td>\n\u20b933.7<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Updates Shared by CARE Ratings in the Latest Financial Results\u00a0<\/b><\/span><\/h2>\n

During the announcements of <\/span>CARE Ratings Q4 results, the company\u2019s management provided key notes on the quarterly results:<\/span><\/p>\n

<\/span>Dividend Announced<\/b><\/span><\/h3>\n

The Board of Directors has recommended a final dividend of \u20b911 per share. Earlier, the company had paid an interim dividend of \u20b97 per share in Q2 FY25. Total dividend for FY25: \u20b918 per share.<\/span><\/p>\n

<\/span>Employee Stock Option Scheme (ESOS) 2020 Update<\/b><\/span><\/h3>\n

The Company has granted a total of 8,11,500 stock options under the ESOS 2020 to eligible employees on various dates, including previous periods.\u00a0<\/span><\/p>\n

These grants have been duly approved by the shareholders and the Nomination & Remuneration Committee.\u00a0<\/span><\/p>\n

In line with Ind AS 102 \u2013 Share-Based Payment, the total cost is being recognised over the vesting period.<\/span><\/p>\n

<\/span>Consolidated Financial Highlights<\/b><\/span><\/h3>\n

In <\/span>CARE Ratings latest results, these are some of the key financial highlights:<\/span><\/p>\n